Purpose
=======

Metabolic syndrome (MetS) is a growing public health concern and effective dietary intervention programs could make a tremendous impact on slowing disease progression. To assess the benefits of a dietary program on cardiometabolic diease risk variables, a 12-week, randomized controlled trial of overweight and obese women with MetS was conducted.

Methods
=======

Participants consumed a Mediterranean-style, low-glycemic-load diet (control arm, n = 44), or the same diet plus a medical food (UltraMeal PLUS 360, Metagenics Inc.) containing phytosterols, soy protein, and extracts from hops and acacia (intervention arm, n = 45). Fasting blood samples were analyzed at baseline, week 8, and week 12 for plasma lipids, apolipoproteins, and homocysteine. Dietary records were collected and analyzed.

Results
=======

Reduction in fat and sugar intake (p \<.001 for both) was observed and increases in docosahexaenoic acid and eicosapentaenoic acid intake (p \<.001 for both) were recorded, consistent with the prescribed diet. Regarding MetS variables, decreases in waist circumference, systolic and diastolic blood pressure, and plasma triglycerides in all subjects (p \<.001 for all) were observed, with no differences between arms. Plasma low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, apolipoprotein (apo) B, and apo B/apo A1 were reduced over the 12-wk study, but to a greater extent in the intervention arm (p \<.05 for all), indicating the medical food had an effect in altering lipoprotein metabolism. Further, medical food intake was associated with reduced plasma homocysteine (p \<.01), compared to the control arm.

Conclusion
==========

A Mediterranean-style, low-glycemic-load diet effectively reduced cardiovascular risk factors associated with MetS. Addition of medical food resulted in an improved lipoprotein profile and lowered plasma homocysteine.
